(Q40596160)

21 September 2017

title

Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate (English)

1 reference

21 September 2017

10

Walter Mier

1 reference

21 September 2017

Qin Wang

1

1 reference

21 September 2017

Keith Graham

2

1 reference

21 September 2017

Thomas Schauer

3

1 reference

21 September 2017

Thomas Fietz

4

1 reference

21 September 2017

Ashour Mohammed

5

1 reference

21 September 2017

Xiuxin Liu

6

1 reference

21 September 2017

Johannes Hoffend

7

1 reference

21 September 2017

Uwe Haberkorn

8

1 reference

21 September 2017

Michael Eisenhut

9

1 reference

21 September 2017

publication date

1 January 2004

1 reference

Nuclear Medicine and Biology

21 September 2017

published in

1 reference

21 September 2017

volume

31

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

21-30

1 reference

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Synthesis, biodistribution and renal handling of various chelate-somatostatin conjugates with metabolizable linking groups

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Lipophilization of somatostatin analog RC-160 improves its bioactivity and stability

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

N-terminal acylation of somatostatin analog with long chain fatty acids enhances its stability and anti-proliferative activity in human breast adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Fluorescent somatostatin receptor probes for the intraoperative detection of tumor tissue with long-wavelength visible light

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Structural Optimization of Non-Nucleotide Loop Replacements for Duplex and Triplex DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Chemistry for peptide and protein PEGylation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

Liquid-liquid partition coefficients by high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900099-4

7 January 2021

10.1016/S0969-8051(03)00099-4

Identifiers

DOI

1 reference

21 September 2017

1 reference